微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 4.01% | 1.01% | 5.8% | 17/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 3.79% | -15.4% | -22.65% | 39/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 4.9% | 5.83% | 15.84% | 34/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 4.23% | 15.57% | 6.55% | 29/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 3.97% | 45.96% | -11.38% | 15/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 4.48% | -27.39% | -3.24% | 37/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 4.63% | -26.16% | 26.5% | 35/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 3.66% | -1.08% | 34.56% | 33/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 2.72% | 40.93% | -55.92% | 28/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 6.17% | 136.75% | -1.59% | 38/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 6.27% | 361.25% | 69.46% | 41/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 3.7% | 1661.91% | 91.71% | 44/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 1.93% | 421.62% | 111.49% | 46/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | -16.79% | -8.96% | -599.58% | 63/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | -2.4% | 48.94% | -1242.86% | 61/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 0.21% | 107.72% | -43.24% | 60/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 0.37% | 76.19% | 102.4% | 57/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | -15.41% | -4180.56% | -227.87% | 62/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | -4.7% | -273.43% | -72.79% | 63/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | -2.72% | -340.71% | -1395.24% | 64/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 0.21% | -81.9% | 158.33% | 61/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | -0.36% | -107.48% | -113.28% | 61/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 2.71% | -63.38% | 139.82% | 56/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 1.13% | -73.47% | -2.59% | 56/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 1.16% | -53.04% | -75.88% | 48/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 4.81% | -73.16% | -35% | 44/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 7.4% | -33.63% | 73.71% | 34/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 4.26% | -40.08% | 72.47% | 38/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 2.47% | -7.14% | -86.22% | 37/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 17.92% | 57.75% | 60.72% | 9/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 11.15% | 89.3% | 56.82% | 13/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 7.11% | 70.91% | 167.29% | 20/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 2.66% | 88.65% | -76.58% | 32/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 11.36% | -19.49% | 92.87% | 27/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 5.89% | -3.6% | 41.59% | 44/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 4.16% | 36.84% | 195.04% | 42/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 1.41% | 27.03% | -90.01% | 45/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 14.11% | 1028.29% | 130.93% | 19/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 6.11% | 1098.04% | 100.99% | 37/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 3.04% | 132% | 173.87% | 47/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 1.11% | 179.29% | 173.03% | 44/68 | 4.17% | 维康药业 | 38.23% | 行业排名> |